NCT06874322 Voiceitt for People With Impairments in Speech
| NCT ID | NCT06874322 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Speech Impairment |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-06-25 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-06-25 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to conditions such as cerebral palsy (CP), stroke, Amyotrophic Lateral Sclerosis (ALS), or Parkinson's disease.
Eligibility Criteria
Inclusion Criteria: * Age 13 or older * moderately severe speech dysarthria due to conditions such as CP, stroke, ALS or Parkinson's Disease, etc. * Ability to understand and follow instructions for using the Voiceitt app. Exclusion Criteria: * Severe cognitive impairments that prevent the understanding of the Voiceitt app and required training. * Patients who have additional speech impairments other than dysarthria, such as significant aphasia or verbal apraxia. * Severe physical impairments that prevent interaction with the app. * Non-English speakers.
Contact & Investigator
Brad E Dicianno, MD
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT06874322 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, studying Speech Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06874322 currently recruiting?
Yes, NCT06874322 is actively recruiting participants. Contact the research team at dicianno@pitt.edu for enrollment information.
Where is the NCT06874322 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT06874322 clinical trial?
NCT06874322 is sponsored by University of Pittsburgh. The principal investigator is Brad E Dicianno, MD at University of Pittsburgh. The trial plans to enroll 20 participants.